p14ARF links the tumour suppressors RB and p53

Stewart Bates, Andrew C. Phillips, Paula A. Clark, Francesca Stott, Gordon Peters, Robert L. Ludwig and Karen H. Vousden ()
Additional contact information
Stewart Bates: ABL Basic research Program
Andrew C. Phillips: ABL Basic research Program
Paula A. Clark: Imperial Cancer Research Fund Laboratories
Francesca Stott: Imperial Cancer Research Fund Laboratories
Gordon Peters: Imperial Cancer Research Fund Laboratories
Robert L. Ludwig: National Cancer Institute, Frederick Cancer Research and Development Center
Karen H. Vousden: National Cancer Institute, Frederick Cancer Research and Development Center

Nature, 1998, vol. 395, issue 6698, 124-125

Abstract: Abstract Most human cancers show perturbation of growth regulation mediated by the tumour-suppressor proteins retinoblastoma (RB) and p53 (ref. 1), indicating that loss of both pathways is necessary for tumour development. Loss of RB function leads to abnormal proliferation related to the deregulation of the E2F transcription factors, but also results in the activation of p53, which suppresses cell growth. Here we show that E2F-1 directly activates expression of the human tumour-suppressor protein p14ARF (the mouse homologue is called p19ARF), which binds to the MDM2-p53 complex and prevents p53 degradation2,5. These results complete a pathway linking abnormal proliferative signals, such as loss of RB, with the activation of a p53 response, through E2F-1 and p14ARF. They suggest that E2F-1, a protein inherently activated by cell-cycle progression, is part of a fail-safe mechanism to protect against aberrant cell growth.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/25867 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:395:y:1998:i:6698:d:10.1038_25867

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/25867

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().